AI Medical Technology
About AI Medical Technology
AI Medical Technology, through its flagship product Dermalyser, offers a CE-marked, AI-driven diagnostic decision support system specifically designed for skin cancer detection, with a primary focus on melanoma. This smartphone application, used in conjunction with a dermatoscope, enables licensed healthcare professionals such as primary care physicians, dermatologists, and general practitioners to capture and analyze dermoscopic images of suspicious skin lesions. The system provides an immediate risk score, aiming to enhance diagnostic precision and speed in clinical settings.
Dermalyser is clinically validated, demonstrating high accuracy with a 96% Area Under the Receiver Operating Characteristic Curve (AUC), 95% sensitivity, and 84.5% specificity for melanoma detection, and notably 100% sensitivity for invasive melanomas. By offering a rapid, accurate “second opinion,” the technology helps minimize false positives, reduce unnecessary referrals and treatments, and optimize clinical workflows, ultimately contributing to improved patient outcomes and reduced healthcare costs. It functions as an intelligent assistant, ensuring that the final diagnostic decision always remains with the physician.
What Physicians Need to Know
For physicians considering Dermalyser, leverage its rapid 5-second analysis for immediate diagnostic support during consultations, especially in primary care settings where quick, accurate initial assessments are crucial. Integrate it into your workflow to reduce unnecessary referrals and improve patient flow, trusting its high sensitivity for melanoma detection, particularly for invasive cases. Remember that Dermalyser is a decision-support tool; the final diagnosis and treatment plan always remain your responsibility. Ensure proper training and adherence to usage guidelines, especially regarding the types of lesions and patient age for which it is validated.
AI Medical Technology offers DermAIM, an AI engine accessible via secure APIs, enabling seamless integration of their clinically validated skin lesion risk assessment capabilities into existing healthcare platforms and systems. This allows for broader adoption and incorporation into various clinical workflows and electronic health records.
What the Web Says
AI Medical Technology, particularly known for its Dermalyser product, receives generally positive feedback for its innovative application of AI in dermatology, improving diagnostic accuracy and efficiency. However, some user experiences highlight a learning curve and potential for integration challenges with existing systems.
Overall: PositiveStrengths
- Enhances diagnostic accuracy in dermatology using AI.
- Improves efficiency in clinical workflows.
- User-friendly interface for medical professionals.
- Potential for early detection of skin conditions.
- Strong focus on medical technology innovation.
- Positive impact on patient care through better diagnostics.
Limitations
- Steep learning curve for some users.
- Potential integration challenges with legacy IT systems.
- Reliance on high-quality image input for optimal performance.
- Cost of implementation and subscription may be a barrier for smaller practices.
- Limited information available on employer reviews (Glassdoor).
- Specific feature requests or improvements mentioned by some users.
Based on reviews from: G2, Capterra, Healthcare IT Reviewers, Reddit
Last updated: 2026-07-30
Videos
News, demos, and interviews about AI Medical Technology.
Videos load interactively. If none appear, search YouTube for AI Medical Technology →
Press & Coverage
Frequently Asked Questions
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie (avie.me) is a healthcare AI company that focuses on providing a next-generation, whole-person health approach, bridging the gap between clinical and holistic care. The company connects individuals with providers and clinicians who can support their unique physical, emotional, cognitive, and logistical needs. Avie emphasizes fusing physical and mental best practices to enhance overall health, […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]
